中国星集团(00326) - 2024 - 年度业绩

Supplemental Announcement Regarding the 2023 Annual Report Details of Share Award Scheme This supplemental announcement provides further details of the Share Award Scheme, primarily focusing on the 164 million award shares granted to Executive Director Ms. Chan on July 12, 2023, which have no vesting period, exercise period, or exercise price Share Award Details | Grantee | Grant Date | Share Awards During the Year | Awarded Shares as of December 31, 2023 | | :--- | :--- | :--- | :--- | | Executive Director: Ms. Chan | July 12, 2023 | 164,000,000 | 164,000,000 | - The 164 million award shares granted to Executive Director Ms. Chan have no vesting period, exercise period, or requirement to pay an exercise price[2] - The closing price of the shares immediately preceding the grant date of the award shares was HK$0.81 per share[3] Scheme Authorization Limit and Utilization Based on the scheme authorization limit approved by shareholders on June 29, 2023, the company can issue up to approximately 246 million shares for the Share Award Scheme and other share schemes, with 164 million shares granted by the end of 2023, representing about 6.67% of total issued shares, leaving approximately 82.09 million shares available for future grants Scheme Authorization and Utilization Summary | Item | Number of Shares | Percentage | | :--- | :--- | :--- | | Total Scheme Authorization Limit | 246,085,047 | Approximately 10% of total issued shares as of the annual report date | | Shares Granted in 2023 | 164,000,000 | 6.67% of weighted average issued shares | | Remaining Available for Grant as of End of 2023 | 82,085,047 | - | - At the Annual General Meeting on June 29, 2023, shareholders approved an updated scheme authorization limit, allowing the company to allot and issue a maximum of 246,085,047 shares for the Share Award Scheme, the amended share option scheme, and any other share schemes[4]